
Sat May 23, 2026 2:00 pm to 5:20 pm EDT
| ScreeningMontreal
VES Members and Their Guests are Invited to an Opening Weekend Screening of Walt Disney Pictures’ STAR WARS: THE MANDALORIAN AND GROGU Followed by a Q&A with the SpFX & VFX team
Panel will include VES Award-, Academy Award-, Emmy- and BAFTA-winning Production Visual Effects Supervisor John Knoll, VES Award- and Emmy-winning Production Visual Effects Producer Abbigale Keller, VES Award-winning Co-Production Visual Effects Supervisor Justin van der Lek and VES Award-, Academy Award-, Emmy- and BAFTA-winning Special Effects Supervisor Scott Fisher, moderated by VES Fellow Paul Debevec, VES. (All panelists’ participation based on availability.)
Please tweet your questions after the screening in order to participate in the Q&A panel (which will take place in Los Angeles) immediately following the screening. (be sure to include the hashtag, #VESGROGU, in your tweet.)
Please RSVP below (VES members must login to sign up)
Saturday, May 23, 2026 at 2:00PM (Doors open at 1:00PM)
Theatre Alanis Obomsawin
1501 rue de Bleury, Montréal, QC H3A 0H3
Click here for a map.
***VES members please register your name in the “Attendee 1″ fields and guests in the subsequent Attendee fields***
In an effort to prevent the spread of COVID-19, we ask that you or your guests do not attend VES events if you are experiencing any symptoms or if you have been exposed to the virus.
Screenings are overbooked to compensate for no-shows. Seating is limited and will be available on a first come, first served basis. An RSVP does not guarantee seating.
By signing up for this on-site, in-person screening/event sponsored by VES (Visual Effects Society), you willingly accept any potential inherent risks associated with COVID-19. VES cannot be held liable from any consequences that may transpire from said risk. Therefore, signing up for this screening/event infers implied consent of yourself and your party and hereby indemnifies and holds harmless VES, its directors, its employees and any other affiliated persons from any adverse medical or financial impact that may result from our participation.